LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 65 of 87
Next
>>
>
1601 to 1625 of 2160 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	NVP-TAE684	3.33	uM	LJP6	2	K14	72	hr	1657	2460	5505	0.4468	0.2085
BT-20	NVP-TAE684	3.33	uM	LJP6	3	K14	72	hr	1657	2781	5505	0.5051	0.2919
BT-20	Palbociclib	3.33	uM	LJP6	1	E14	72	hr	1657	2240	5505	0.4069	0.1513
BT-20	Palbociclib	3.33	uM	LJP6	2	E14	72	hr	1657	2359	5505	0.4285	0.1822
BT-20	Palbociclib	3.33	uM	LJP6	3	E14	72	hr	1657	2617	5505	0.4753	0.2493
BT-20	PD0325901	3.33	uM	LJP5	1	C02	72	hr	1657	3940	5505	0.7156	0.5931
BT-20	PD0325901	3.33	uM	LJP5	2	C02	72	hr	1657	3981	5505	0.7231	0.6038
BT-20	PD0325901	3.33	uM	LJP5	3	C02	72	hr	1657	4198	5505	0.7625	0.6602
BT-20	PD0325901	3.33	uM	LJP6	1	E02	72	hr	1657	3299	5505	0.5992	0.4265
BT-20	PD0325901	3.33	uM	LJP6	2	E02	72	hr	1657	3413	5505	0.6199	0.4562
BT-20	PD0325901	3.33	uM	LJP6	3	E02	72	hr	1657	3797	5505	0.6897	0.5560
BT-20	PD173074	3.33	uM	LJP6	1	I08	72	hr	1657	6354	5505	1.1541	1.2205
BT-20	PD173074	3.33	uM	LJP6	2	I08	72	hr	1657	6819	5505	1.2385	1.3413
BT-20	PD173074	3.33	uM	LJP6	3	I08	72	hr	1657	5940	5505	1.0789	1.1129
BT-20	PD184352	3.33	uM	LJP5	1	L08	72	hr	1657	5360	5505	0.9735	0.9621
BT-20	PD184352	3.33	uM	LJP5	2	L08	72	hr	1657	5356	5505	0.9728	0.9611
BT-20	PD184352	3.33	uM	LJP5	3	L08	72	hr	1657	5480	5505	0.9953	0.9933
BT-20	Pelitinib	3.33	uM	LJP5	1	I14	72	hr	1657	4402	5505	0.7995	0.7132
BT-20	Pelitinib	3.33	uM	LJP5	2	I14	72	hr	1657	4496	5505	0.8166	0.7376
BT-20	Pelitinib	3.33	uM	LJP5	3	I14	72	hr	1657	4163	5505	0.7561	0.6511
BT-20	PF431396	3.33	uM	LJP5	1	E08	72	hr	1657	1865	5505	0.3387	0.0539
BT-20	PF431396	3.33	uM	LJP5	2	E08	72	hr	1657	1974	5505	0.3585	0.0822
BT-20	PF431396	3.33	uM	LJP5	3	E08	72	hr	1657	1982	5505	0.3600	0.0843
BT-20	PF477736	3.33	uM	LJP5	1	J20	72	hr	1657	4440	5505	0.8064	0.7231
BT-20	PF477736	3.33	uM	LJP5	2	J20	72	hr	1657	4699	5505	0.8535	0.7904

|<
<<
Previous
Page 65 of 87
Next
>>
>
1601 to 1625 of 2160 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)